Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan. [electronic resource]
Producer: 20201201Description: 231-238 p. digitalISSN:- 2055-6845
- Acute Coronary Syndrome -- diagnosis
- Aged
- Aged, 80 and over
- Clopidogrel -- administration & dosage
- Coronary Thrombosis -- mortality
- Databases, Factual
- Female
- Hemorrhage -- chemically induced
- Hospital Mortality
- Hospitalization
- Humans
- Incidence
- Japan -- epidemiology
- Male
- Middle Aged
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Prasugrel Hydrochloride -- administration & dosage
- Propensity Score
- Prospective Studies
- Registries
- Risk Assessment
- Risk Factors
- ST Elevation Myocardial Infarction -- diagnosis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.